DAWN HALKUFF

Business address
C/O Xeris Pharmaceuticals, 180 N. Lasalle St., Ste. 1800, Chicago, IL, 60601
Top holdings (ownership)
XERS
⭐ Add to watchlist ⭐
Get insider transactions for this reporting owner
DAWN HALKUFF has filed 14 SEC EDGAR filings since 20 Jun 2018

Latest Filings

Form type Document Filing Description Filing date Reporting date File number(s)
4 Open Document Open Filing FORM 4 13 Aug 2025 12 Aug 2025 001-40880
144 Open Document Open Filing 12 Aug 2025
4 Open Document Open Filing FORM 4 04 Jun 2025 04 Jun 2025 001-40880
4 Open Document Open Filing FORM 4 05 Jun 2024 05 Jun 2024 001-40880
4 Open Document Open Filing FORM 4 21 Nov 2023 20 Nov 2023 001-40880
4 Open Document Open Filing FORM 4 07 Jun 2023 07 Jun 2023 001-40880
4 Open Document Open Filing FORM 4 09 Jun 2022 08 Jun 2022 001-40880
4 Open Document Open Filing FORM 4 SUBMISSION 05 Oct 2021 05 Oct 2021 001-40880
4 Open Document Open Filing FORM 4 SUBMISSION 05 Oct 2021 05 Oct 2021 001-38536
3 Open Document Open Filing FORM 3 05 Oct 2021 05 Oct 2021 001-40880
4 Open Document Open Filing FORM 4 08 Jun 2021 08 Jun 2021 001-38536
4 Open Document Open Filing FORM 4 SUBMISSION 04 Jun 2020 04 Jun 2020 001-38536
4 Open Document Open Filing FORM 4 SUBMISSION 01 Mar 2019 27 Feb 2019 001-38536
3 Open Document Open Filing FORM 3 SUBMISSION 20 Jun 2018 20 Jun 2018 001-38536